Robert L. Wolen

1.3k total citations
37 papers, 1.0k citations indexed

About

Robert L. Wolen is a scholar working on Pharmacology, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Robert L. Wolen has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Biology and 7 papers in Analytical Chemistry. Recurrent topics in Robert L. Wolen's work include Analytical Chemistry and Chromatography (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Robert L. Wolen is often cited by papers focused on Analytical Chemistry and Chromatography (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Robert L. Wolen collaborates with scholars based in United States, United Kingdom and Denmark. Robert L. Wolen's co-authors include Louis Lemberger, R. F. Bergstrom, Nazar Farid, Charles M. Gruber, George R. Aronoff, Alan Rubin, Gregory G. Enas, Richard F. Bergstrom, Anthony S. Ridolfo and Glenn F. Kiplinger and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Robert L. Wolen

36 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Wolen United States 15 362 195 181 166 127 37 1.0k
B. Alexanderson Sweden 13 349 1.0× 254 1.3× 296 1.6× 98 0.6× 134 1.1× 15 880
Soong T. Chiang United States 17 306 0.8× 170 0.9× 227 1.3× 70 0.4× 93 0.7× 35 800
G.J. Krol United States 18 398 1.1× 143 0.7× 135 0.7× 163 1.0× 190 1.5× 37 1.1k
J Heykants Belgium 20 229 0.6× 218 1.1× 249 1.4× 100 0.6× 207 1.6× 37 1.3k
Samuel F. Sisenwine United States 18 240 0.7× 115 0.6× 298 1.6× 203 1.2× 237 1.9× 56 1.1k
Gilles Caillé Canada 20 357 1.0× 110 0.6× 210 1.2× 162 1.0× 135 1.1× 73 1.1k
Barry D. Zussman United Kingdom 15 344 1.0× 253 1.3× 218 1.2× 64 0.4× 152 1.2× 20 915
B. Norlander Sweden 23 281 0.8× 100 0.5× 153 0.8× 195 1.2× 168 1.3× 53 1.1k
Frans M. Belpaire Belgium 19 312 0.9× 112 0.6× 211 1.2× 112 0.7× 233 1.8× 52 1.3k
G. Bianchetti France 21 277 0.8× 255 1.3× 184 1.0× 101 0.6× 163 1.3× 78 1.5k

Countries citing papers authored by Robert L. Wolen

Since Specialization
Citations

This map shows the geographic impact of Robert L. Wolen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Wolen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Wolen more than expected).

Fields of papers citing papers by Robert L. Wolen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Wolen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Wolen. The network helps show where Robert L. Wolen may publish in the future.

Co-authorship network of co-authors of Robert L. Wolen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Wolen. A scholar is included among the top collaborators of Robert L. Wolen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Wolen. Robert L. Wolen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fossella, Frank V., Scott M. Lippman, David E. Seitz, et al.. (1991). Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: Report of three cases. Investigational New Drugs. 9(4). 357–359. 2 indexed citations
2.
Hartman, Boyd K., D S Miyada, Hubert Pirkle, et al.. (1988). Serum Propoxyphene Concentrations in a Cohort of Opiate Addicts on Long-Term Propoxyphene Maintenance Therapy. Evidence for Drug Tolerance in Humans. Journal of Analytical Toxicology. 12(1). 25–29. 1 indexed citations
3.
Bergstrom, R. F., Louis Lemberger, Nazar Farid, & Robert L. Wolen. (1988). Clinical Pharmacology and Pharmacokinetics of Fluoxetine: A Review. The British Journal of Psychiatry. 153(S3). 47–50. 121 indexed citations
4.
Schenker, Steven, Richard F. Bergstrom, Robert L. Wolen, & Louis Lemberger. (1988). Fluoxetine disposition and elimination in cirrhosis. Clinical Pharmacology & Therapeutics. 44(3). 353–359. 56 indexed citations
5.
Rubin, Alan, et al.. (1985). Stereoselective Inversion of (R)-Fenoprofen to (S)-Fenoprofen in Humans. Journal of Pharmaceutical Sciences. 74(1). 82–84. 92 indexed citations
6.
Lemberger, Louis, R. F. Bergstrom, Robert L. Wolen, et al.. (1985). Fluoxetine: clinical pharmacology and physiologic disposition.. PubMed. 46(3 Pt 2). 14–9. 170 indexed citations
7.
Lemberger, Louis, Richard Bergstrom, George R. Aronoff, Nazar Farid, & Robert L. Wolen. (1984). SPECIFIC SEROTONIN UPTAKE BLOCKERS. Clinical Neuropharmacology. 7. S172–S172. 1 indexed citations
8.
Diven, Warren F., Boyd D. Obermeyer, Robert L. Wolen, et al.. (1981). Measurement of Serum and Tissue Concentration of Moxalactam Using High Pressure Liquid Chromatography. Therapeutic Drug Monitoring. 3(3). 291–296. 12 indexed citations
9.
Black, Henry R., Karen Israel, Robert L. Wolen, et al.. (1979). Pharmacology of Cinoxacin in Humans. Antimicrobial Agents and Chemotherapy. 15(2). 165–170. 23 indexed citations
10.
Wolen, Robert L., et al.. (1979). The effect of crystal size on the bioavailability of benoxaprofen: Studies utilizing deuterium labeled drug. Journal of Mass Spectrometry. 6(4). 173–178. 18 indexed citations
11.
Rubin, Alan, Louis Lemberger, Ross E. Crabtree, et al.. (1978). Physiologic disposition of lergotrile. Clinical Pharmacology & Therapeutics. 23(3). 272–280. 4 indexed citations
12.
Rubin, Alan, et al.. (1974). A PHARMACOKINETIC INTERACTION IN MAN BETWEEN PHENOBARBITONE AND FENOPROFEN, A NEW ANTI‐INFLAMMATORY AGENT. British Journal of Clinical Pharmacology. 1(5). 371–374. 17 indexed citations
13.
Crabtree, Ross E., et al.. (1973). Tracer microspheres as a fecal marker in balance studies. Clinical Pharmacology & Therapeutics. 14(6). 987–991. 5 indexed citations
14.
Rubin, Alan, et al.. (1972). PHYSIOLOGICAL DISPOSITION OF FENOPROFEN IN MAN. III. METABOLISM AND PROTEIN BINDING OF FENOPROFEN. Journal of Pharmacology and Experimental Therapeutics. 183(2). 449–457. 15 indexed citations
15.
Cerimele, Benito J., et al.. (1972). Computerized Automation in Acquisition and Processing of Patterns from High-Pressure Ion-Exchange Chromatography. Clinical Chemistry. 18(8). 744–748. 8 indexed citations
16.
Wolen, Robert L., et al.. (1971). Concentration of propoxyphene in human plasma following repeated oral doses. Toxicology and Applied Pharmacology. 19(3). 493–497. 20 indexed citations
17.
Gruber, Charles M., et al.. (1971). Analgesia scores as timed responses following oral administration of propoxyphene to postpartum patients. Toxicology and Applied Pharmacology. 19(3). 504–511. 9 indexed citations
18.
Rodda, Bruce E., et al.. (1971). Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case II—Equipotent doses. Toxicology and Applied Pharmacology. 19(3). 563–571. 6 indexed citations
19.
Wolen, Robert L. & Charles M. Gruber. (1968). Determination of propoxyphene in human plasma by gas chromatography. Analytical Chemistry. 40(8). 1243–1246. 53 indexed citations
20.
Wolen, Robert L. & John C. Wriston. (1963). On the Oxidation of d-1, 3-Thiazane-4-carboxylic Acid (d-Tetrahydro-1, 3-thiazine-4-carboxylic Acid). Journal of Biological Chemistry. 238(1). 377–380. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Alexanderson Breakdown of academic impact, for papers by Soong T. Chiang Breakdown of academic impact, for papers by G.J. Krol Breakdown of academic impact, for papers by J Heykants Breakdown of academic impact, for papers by Samuel F. Sisenwine Breakdown of academic impact, for papers by Gilles Caillé Breakdown of academic impact, for papers by Barry D. Zussman Breakdown of academic impact, for papers by B. Norlander Breakdown of academic impact, for papers by Frans M. Belpaire Breakdown of academic impact, for papers by G. Bianchetti
Rankless by CCL
2026